Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Small Cell Lung Carcinoma 1Sleep Wake Disorders 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Multiple Myeloma 1Melanoma 1Malignant Solid Neoplasm 1Malignant Primary Pelvic Neoplasm 1Lymphoma, Non-Hodgkin 1Leukemia, Lymphocytic, Chronic, B-Cell 1Inflammatory Breast Neoplasms 1Hodgkin Disease 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Heart Defects, Congenital 1Fatigue 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8 1Carcinoma, Merkel Cell 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 15fludarabine 12Mycophenolic Acid 10Standard of Care 8venetoclax 7Whole-Body Irradiation 7Tacrolimus 7Specimen Handling 7Sirolimus 6trametinib 5Practice Guidelines as Topic 5Azacitidine 5fludarabine phosphate 4Melphalan 4Magnetic Resonance Spectroscopy 4Biopsy 4Rituximab 3Radiosurgery 3Peripheral Blood Stem Cell Transplantation 3Mesna 3Interviews as Topic 3Granulocyte Colony-Stimulating Factor 3GSK2636771 3Filgrastim 3Cytarabine 3Crizotinib 3Busulfan 3Behavior Therapy 3talquetamab 2ruxolitinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Exercise Test × 90 days × Clear all
NCT05106374 2026-04-13

Risk of Chemotherapy Toxicity in Older Patients With Blood Cancer or Non-small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Completed
182 enrolled
Other hematologic neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡